Respiro Diagnostics
Develops breath-based diagnostic platform for lung cancer and respiratory diseases
£1MPre-Seed
Role not disclosedSC
SFC Capital
sfccapital.com ↗Activity from announced rounds
Activity in this selectionOct 24, 2026 · Biotech · Jan 1, 2026
SFC Capital provides seed capital and support to early-stage British companies through its funds and angel network.
Investment approach
The firm combines its seed funds with an angel syndicate and invests across sectors. Its official portfolio includes software, healthcare, financial technology and hardware businesses.
Activity recorded by RoundOS
RoundOS records include Anemo Labs’ electronic nose and Respiro Diagnostics’ breath-based diagnostics. Other recorded financings cover Kord’s identity and payments infrastructure, Healome’s eye-drop technology, BidScript’s tender software and Pontiro’s medical-imaging data tools.
These examples describe financings recorded in RoundOS, rather than the investor’s complete portfolio.
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $4M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionHealome Therapeutics
Develops proprietary eye-drop matrix technology for ocular surface diseases
£2MSeed
Role not disclosed